Abbott Laboratories buy Argus
Start price
31.01.25
/
50%
€123.82
Target price
31.01.26
-
Performance (%)
-25.46%
End price
01.02.26
€92.30
Summary
This prediction ended on 01.02.26 with a price of €92.30. The price of Abbott Laboratories has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -25.46%. Argus has a follow-up prediction for Abbott Laboratories where he still thinks Abbott Laboratories is a Buy. Argus has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Abbott Laboratories | -2.588% | -2.588% | -37.220% |
| iShares Core DAX® | -0,47 % | 0,92 % | 3,02 % |
| iShares Nasdaq 100 | 4,19 % | 15,86 % | 33,32 % |
| iShares Nikkei 225® | -0,07 % | 8,10 % | 47,96 % |
| iShares S&P 500 | 2,68 % | 8,75 % | 22,97 % |
Comments by Argus for this prediction
In the thread Discuss Abbott Laboratories
Abbott Laboratories (NYSE: ABT) was upgraded by analysts at Argus to a "strong-buy" rating.
Ratings data for ABT provided by MarketBeat
In the thread Trading Abbott Laboratories
Die von Argus gewählte maximale Laufzeit wurde überschritten
Current prediction by Argus for Abbott Laboratories
Abbott Laboratories
Start price
Target price
Perf. (%)
€81.00
21.04.26
21.04.26
€106.13
21.04.27
21.04.27
-10.25%
22:25
22:25
